Skip to main content
. 2019 Apr;23(4):175–177. doi: 10.5005/jp-journals-10071-23148

Table 2.

Analysis of 27 ICSRs containing 53 AMAs for suspected adverse drug reactions

AMAs (n) Route of administration Severity of hypokalemia Outcome Causality assessment
IV PO Mild Moderate Severe Recovered Continued
Ceftriaxone (14) 13 00 10 03 01 02 12 Possible
Azithromycin (06) 01 05 05 01 Nil 01 05 Possible
Metronidazole (05) 03 02 02 03 Nil 00 05 Possible
Ciprofloxacin (03) 02 01 Nil 03 Nil 00 03 Possible
Others (29) 13 16 12 16 01 01 28 Possible